Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $51.34 ($1.3M) on 2019-06-12, disclosed to the SEC on 2019-06-13.
Seasonal sale ($1.3M) by Chief Scientific Officer — this insider has traded GHDX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $1.3M | — | Filing → |